Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01974349 | To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers | completed | Phase 1 | 39 | AstraZenecaINDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | completed | Phase 1 | 28 | Children's Oncology GroupNETWORK | 3 | Aug 8, 2014 | clinicaltrials |
| NCT00458744 | Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment | withdrawn | Phase 1 | 0 | Children's Oncology GroupNETWORK | 0 | Aug 8, 2014 | clinicaltrials |
| NCT01215864 | Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | Traslational Cancer Drugs Pharma, SLINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00107458 | Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors | completed | Phase 1 | 26 | Children's Oncology GroupNETWORK | 2 | Aug 7, 2014 | clinicaltrials |
| NCT00567931 | 1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT01191216 | 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT00847054 | A Study of of MORAb-004 in Subjects With Solid Tumors | completed | Phase 1 | 80 | MorphotekINDUSTRY | 1 | Jul 16, 2014 | clinicaltrials |
| NCT00002948 | High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | terminated | Phase 1 | — | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00759928 | PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors | completed | Phase 1 | 48 | SCRI Development Innovations, LLCOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01222546 | Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Chugai Pharma Europe Ltd.INDUSTRY | 1 | Jun 23, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00609141 | IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT01005355 | Study of IMC-1121B in Patients With Advanced Solid Tumors | completed | Phase 1 | 15 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT00058253 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00121264 | 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00217412 | Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT01631279 | A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors | terminated | Phase 1 / Phase 2 | 33 | Proacta, IncorporatedINDUSTRY | 2 | Jun 16, 2014 | clinicaltrials |
| NCT00104962 | Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01401504 | Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors | completed | Phase 1 | 29 | Astellas Pharma IncINDUSTRY | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00729833 | Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors | terminated | Phase 1 | 45 | PfizerINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT00483093 | Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor | completed | Phase 1 | 22 | AGC Biologics S.p.A.INDUSTRY | 1 | May 30, 2014 | clinicaltrials |
| NCT01198184 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT01217450 | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | May 29, 2014 | clinicaltrials |
| NCT00003009 | Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer | terminated | Phase 1 | 16 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01170871 | Ixabepilone and Pemetrexed/Solid Tumors | withdrawn | Phase 1 | 0 | University of Southern CaliforniaOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00415324 | Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00606437 | Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants | completed | Phase 1 | 40 | Duke UniversityOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT01581060 | Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours | terminated | Phase 1 / Phase 2 | 41 | Heidelberg Pharma AGINDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT01859351 | Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours | terminated | Phase 1 | 13 | Heidelberg Pharma AGINDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT01957280 | Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287) | completed | Phase 1 | 17 | Daiichi SankyoINDUSTRY | 1 | May 14, 2014 | clinicaltrials |
| NCT01240538 | Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 26 | National Cancer Institute (NCI)NIH | 2 | May 13, 2014 | clinicaltrials |
| NCT00147225 | AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | completed | Phase 1 / Phase 2 | 55 | M.D. Anderson Cancer CenterOTHER | 1 | May 8, 2014 | clinicaltrials |
| NCT00008424 | Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants | completed | Phase 1 | 7 | Children's Oncology GroupNETWORK | 3 | May 5, 2014 | clinicaltrials |
| NCT01018836 | Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | terminated | Phase 1 | 9 | Rutgers, The State University of New JerseyOTHER | 1 | May 2, 2014 | clinicaltrials |
| NCT00933985 | Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia | terminated | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 2 | May 1, 2014 | clinicaltrials |
| NCT00880282 | Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment | completed | Phase 1 | 39 | National Cancer Institute (NCI)NIH | 2 | Apr 29, 2014 | clinicaltrials |
| NCT01231919 | MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 2 | Apr 29, 2014 | clinicaltrials |
| NCT02046850 | To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers | completed | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Apr 29, 2014 | clinicaltrials |
| NCT00002923 | KRN5500 in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 27 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00028548 | XK469 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00004144 | Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 36 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT01235897 | MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies | completed | Phase 1 | 17 | University of California, San FranciscoOTHER | 1 | Apr 17, 2014 | clinicaltrials |
| NCT00003250 | Fenretinide in Treating Patients With Solid Tumors | completed | Phase 1 | 31 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 11, 2014 | clinicaltrials |
| NCT01141244 | Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 72 | National Cancer Institute (NCI)NIH | 2 | Apr 10, 2014 | clinicaltrials |
| NCT01725555 | A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors | completed | Phase 1 | 13 | Axelar ABINDUSTRY | 1 | Apr 7, 2014 | clinicaltrials |
| NCT00544596 | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01096355 | Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01243359 | Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies | completed | Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Aug 13, 2014source: clinicaltrials